Related references
Note: Only part of the references are listed.Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
J. R. van Beijnum et al.
ONCOGENE (2013)
mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method
Baris Karakullukcu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
Patrycja Nowak-Sliwinska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
Anne Q. Reuwer et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement
C. Porta et al.
MEDICAL ONCOLOGY (2012)
Antiangiogenic Therapy for Cancer: An Update
Belal Al-Husein et al.
PHARMACOTHERAPY (2012)
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
Y. Adar et al.
CELL DEATH & DISEASE (2012)
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma
Ronald M. Bukowski
FRONTIERS IN ONCOLOGY (2012)
AXITINIB, A NEW THERAPEUTIC OPTION IN RENAL CELL CARCINOMA
E. R. Kessler et al.
DRUGS OF TODAY (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Brian I. Rini et al.
LANCET (2011)
Antiangiogenesis Agents Avastin and Erbitux Enhance the Efficacy of Photodynamic Therapy in a Murine Bladder Tumor Model
Ramaswamy Bhuvaneswari et al.
LASERS IN SURGERY AND MEDICINE (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
One-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Ayana Yamashita et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Kristy J. Gotink et al.
ANGIOGENESIS (2010)
Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2010)
Angiostasis-induced vascular normalization can improve photodynamic therapy
Patrycja Nowak-Sliwinska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model
Patrycja Nowak-Sliwinska et al.
MICROVASCULAR RESEARCH (2010)
The Neovessel Occlusion Efficacy of 151-Hydroxypurpurin-7-Lactone Dimethyl Ester Induced with Photodynamic Therapy
Siang Hui Lim et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2010)
Sunitinib A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies
Georgios S. Papaetis et al.
BIODRUGS (2009)
Combination Therapy Using Verteporfin and Ranibizumab; Optimizing the Timing in the CAM Model
Elodie Debefve et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2009)
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): Year 2 results
Andrew N. Antoszyk et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Axitinib for renal cell carcinoma
Guru Sonpavde et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients
Fumi Gomi et al.
OPHTHALMOLOGY (2008)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Dai Fukumura et al.
MICROVASCULAR RESEARCH (2007)
A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer
Boleslav Kosharskyy et al.
CANCER RESEARCH (2006)
Current status of angiogenesis inhibitors combined with radiation therapy
Carsten Nieder et al.
CANCER TREATMENT REVIEWS (2006)
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models
QY Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo
MG del Carmen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Trimodal cancer treatment:: Beneficial effects of combined antianglogenesis, radiation, and chemotherapy
PE Huber et al.
CANCER RESEARCH (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage
AM Soler et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration
U Schmidt-Erfurth et al.
SURVEY OF OPHTHALMOLOGY (2000)
Share Paper
